ULTRA V

Based in South Korea, UltraV is a cosmeceutical company that specializes in advanced medical devices and cosmetic products, focusing on skin recovery and rejuvenation solutions for healthcare professionals and consumers. Founded in 2012, UltraV operates from its headquarters in Seoul, South Korea. The company focuses on developing innovative solutions in the cosmeceutical sector. Specific details regarding funding rounds and operational pivots were not found.

UltraV specializes in advanced medical devices and cosmetic products, with a prominent focus on their flagship product, UltraCol. Utilizing proprietary PDO Microsphere technology, UltraCol is designed for skin recovery and antioxidant effects, and stands out as a unique offering in the market. The company has expanded its presence internationally, operating in over 51 countries and partnering with 43 distributors to enhance its global reach. Their clientele includes medical professionals and clinics that utilize these products for aesthetic and therapeutic purposes, catering to end users seeking skin rejuvenation solutions.

UltraV's products are available in diverse markets including Australia, New Zealand, various countries in Asia such as China and Japan, and European nations including Germany and France. UltraV generates revenue through direct sales of its medical devices and cosmetic products, primarily targeting healthcare professionals and beauty clinics. The company’s transaction structure is based on B2B models, where medical institutions purchase UltraCol and related products for clinical use. Clients may engage in partnerships or bulk purchasing agreements, facilitating a steady revenue stream while ensuring distribution across their extensive global network.

While specific pricing plans for UltraCol and related product offerings are proprietary, the company’s sales have reportedly surpassed 17 million units. This strong sales performance reflects the products' acceptance and effectiveness in the market, contributing to UltraV's overall financial stability. Future growth strategies for UltraV include the development of new products aimed at enhancing their existing range, with specific details on release dates not provided. The company plans to target expansion into markets such as North America and various regions in Europe by the end of 2025.

Recent funding will be directed towards supporting these initiatives, strengthening their international market presence, and facilitating product development efforts.